| PERIOD ENDING | 31-Dec-08 | 31-Dec-07 | 31-Dec-06 | | Total Revenue | 7,795,494 | 15,920,478 | 14,550,236 | | Cost of Revenue | 4,155,473 | 8,077,081 | 7,187,938 | | | Gross Profit | 3,640,021 | 7,843,397 | 7,362,298 | | | Operating Expenses | | Research Development |
-
|
-
|
-
| | Selling General and Administrative | 2,792,999 | 5,772,197 | 5,395,361 | | Non Recurring | 279,445 | 439,406 | 188,074 | | Others | 5,792 | 57,922 | 103,832 | | | | Total Operating Expenses |
-
|
-
|
-
| | | | Operating Income or Loss | 561,785 | 1,573,872 | 1,675,031 | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 211,393 | (251,660) | 45,059 | | Earnings Before Interest And Taxes | 787,658 | 1,338,191 | 1,720,090 | | Interest Expense | 208,498 |
-
| 383,984 | | Income Before Tax | 579,160 | 1,338,191 | 1,336,106 | | Income Tax Expense | 43,437 | 525,290 | 391,820 | | Minority Interest |
-
|
-
|
-
| | | | Net Income From Continuing Ops | 535,723 | 812,901 | 912,941 | | | Non-recurring Events | | Discontinued Operations | (5,792) |
-
| 1,112,769 | | Extraordinary Items |
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
| | Other Items |
-
|
-
|
-
| | | | Net Income | 529,931 | 812,901 | 2,025,709 | | Preferred Stock And Other Adjustments |
-
|
-
|
-
| | | Net Income Applicable To Common Shares | $529,931 | $812,901 | $2,025,709 |
|
0.10% Nasdaq 
0.27%
Income Statement
